Novo Nordisk A/S
Copenhagen : NOVO B

September 29, 2011 16:02 ET

Novo Nordisk files for regulatory approval of the ultra-long-acting insulins Degludec and DegludecPlus in the US

BAGSVæRD, DENMARK--(Marketwire - Sep 29, 2011) -

Company Announcement no 61 / 2011:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE


Contact Information